- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/40 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 307/40
Total number of patents in this class: 59
10-year publication summary
|
3
|
5
|
4
|
3
|
1
|
4
|
3
|
3
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Massachusetts Institute of Technology | 10251 |
4 |
| The General Hospital Corporation | 4870 |
4 |
| Archer Daniels Midland Company | 1075 |
4 |
| Promega Corporation | 589 |
4 |
| Janssen Pharmaceutica N.V. | 3168 |
2 |
| Eastman Chemical Company | 2087 |
2 |
| Furanix Technologies B.V. | 130 |
2 |
| Omeros Corporation | 305 |
2 |
| Regents of the University of Minnesota | 2789 |
2 |
| Roquette Freres | 1051 |
2 |
| Stora Enso Oyj | 1653 |
2 |
| Janssen Biopharma, Inc. | 32 |
2 |
| Resource Chemical Corporation | 2 |
2 |
| The Regents of the University of California | 20745 |
1 |
| Allergan, Inc. | 2167 |
1 |
| Henkel AG & Co. KGaA | 10770 |
1 |
| Biotropics Malaysia Bhd | 23 |
1 |
| The Coca-Cola Company | 2443 |
1 |
| Daito Chemix Corporation | 12 |
1 |
| E-Therapeutics PLC | 67 |
1 |
| Other owners | 18 |